# Eupraxia Pharmaceuticals Inc. (EPRX): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for Eupraxia Pharmaceuticals Inc. (EPRX) is 23/100, ranked against 25,000+ stocks in 38 markets (Quality 30, Value 25, Momentum 53, each scored against its sector).

- MoatMap Score: 23/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 30, Value 25, Momentum 53: each a 0-100 percentile within Healthcare.
- Position: #20,551 overall, #1,813 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 7.81 USD on 12 Nov 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/EPRX
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker